Century Sage Scientific Holdings Ltd (HK:1450)
:1450
Want to see HK:1450 full AI Analyst Report?
Top Page
Century Sage Scientific Holdings Ltd
(1450)
Select Model
Select Model
Rating:74Outperform
Price Target:
HK$1.00
▼(-12.28% Downside)
Action:Upgraded
Date:05/20/26
The score is driven primarily by improved financial performance (revenue growth, sustained profitability, and lower leverage), tempered by margin compression and inconsistent cash-flow history. Technicals are moderately positive (above key short/intermediate averages and higher RSI) but not fully confirmed by long-term trend (below 200-day) and a slightly negative MACD. Valuation is supportive given the low P/E, though dividend yield data is unavailable.
Positive Factors
Revenue Scaling
Sustained top-line expansion from 2022–2025 indicates the company is gaining market traction and expanding product adoption. Durable revenue growth supports investment in R&D and sales, helps absorb fixed costs, and underpins medium-term cash generation and strategic positioning versus peers.
Negative Factors
Margin Compression
Material margin deterioration since 2023 suggests rising costs or pricing pressure that erode operating leverage. If structural, this reduces sustainable profitability and free cash flow conversion, limiting capacity to fund growth or returns and raising the bar for efficiency improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Scaling
Sustained top-line expansion from 2022–2025 indicates the company is gaining market traction and expanding product adoption. Durable revenue growth supports investment in R&D and sales, helps absorb fixed costs, and underpins medium-term cash generation and strategic positioning versus peers.
Read all positive factors
Century Sage Scientific Holdings Ltd (1450) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.34B
Dividend YieldN/A
Average Volume (3M)1.96M
Price to Earnings (P/E)15.6
Beta (1Y)0.49
Revenue Growth19.09%
EPS Growth6.34%
CountryHK
Employees1,163
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.07
Shares Outstanding1,407,203,100
10 Day Avg. Volume2,198,140
30 Day Avg. Volume1,964,156
Financial Highlights & Ratios
PEG Ratio1.43
Price to Book (P/B)2.65
Price to Sales (P/S)0.95
P/FCF Ratio4.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.24
Revenue Forecast (FY)HK$2.33B
Century Sage Scientific Holdings Ltd Business Overview & Revenue Model
Company Description
Be Friends Holding Ltd. is an investment company, which engages in the provision of hardware and software all-media application solutions. It operates through the following business segments: New Media Services, Application Solutions, System Maint...
How the Company Makes Money
null...
Century Sage Scientific Holdings Ltd Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
70
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.49B | 1.25B | 1.07B | 425.61M | 202.79M |
| Gross Profit | 603.23M | 599.30M | 566.91M | 189.80M | 60.33M |
| EBITDA | 140.67M | 119.87M | 184.30M | 19.76M | -22.52M |
| Net Income | 90.22M | 81.71M | 119.46M | -9.21M | -61.62M |
Balance Sheet | |||||
| Total Assets | 946.26M | 923.92M | 754.59M | 446.91M | 422.68M |
| Cash, Cash Equivalents and Short-Term Investments | 360.53M | 113.32M | 149.54M | 50.93M | 111.06M |
| Total Debt | 93.33M | 252.83M | 168.96M | 151.23M | 182.62M |
| Total Liabilities | 414.28M | 510.21M | 452.88M | 343.92M | 334.29M |
| Stockholders Equity | 532.02M | 418.99M | 297.51M | 93.30M | 65.80M |
Cash Flow | |||||
| Free Cash Flow | 351.21M | -45.69M | 167.14M | -6.90M | 7.43M |
| Operating Cash Flow | 357.92M | -27.58M | 182.99M | -2.08M | 7.81M |
| Investing Cash Flow | -136.97M | -58.44M | -74.47M | 32.34M | 4.28M |
| Financing Cash Flow | -19.90M | 52.47M | -10.28M | -34.83M | 36.10M |
Century Sage Scientific Holdings Ltd Technical Analysis
Positive
1.14
Price Trends
0.78
Positive
0.90
Positive
0.98
Negative
Market Momentum
0.01
Negative
72.89
Negative
80.54
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1450, the sentiment is Positive. The current price of 1.14 is above the 20-day moving average (MA) of 0.76, above the 50-day MA of 0.78, and above the 200-day MA of 0.98, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 72.89 is Negative, neither overbought nor oversold. The STOCH value of 80.54 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1450.
Century Sage Scientific Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.34B | 15.60 | 17.92% | ― | 19.09% | 6.34% | |
67 Neutral | HK$1.85B | 31.05 | 6.59% | ― | 18.62% | 8.38% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | HK$2.64B | 21.92 | 6.36% | 1.38% | 17.22% | 385.91% | |
48 Neutral | HK$155.89M | -25.83 | -1.65% | ― | 67.24% | ― | |
46 Neutral | HK$2.53B | ― | -3.66% | ― | ― | ― | |
45 Neutral | HK$679.32M | -10.58 | -18.42% | ― | -33.72% | -910.29% |
* Technology Sector Average
HK:1450
Century Sage Scientific Holdings Ltd
0.95
0.03
3.26%
HK:2392
Xuan Wu Cloud Technology Holdings Limited
1.22
0.25
25.77%
HK:8156
Sinopharm Tech Holdings Limited
0.25
0.13
105.00%
HK:9885
YSB Inc.
3.90
-4.36
-52.78%
HK:2576
Zhejiang Taimei Medical Technology Co Ltd Class H
4.49
1.14
34.03%
HK:2571
Beijing Saimo Technology Co. Ltd. Class H
13.85
0.95
7.36%
Century Sage Scientific Holdings Ltd Corporate Events
Be Friends Holding Sets 2026 AGM to Approve Dividend, Board Mandates
Apr 27, 2026
Be Friends Holding Limited has called its annual general meeting for 16 June 2026 in Hangzhou, where shareholders will review the audited financial statements for the year ended 31 December 2025 and vote on a proposed final dividend of HK$0.05 per...
Be Friends Holding Grants 6.45 Million Awarded Shares to Senior Staff
Apr 10, 2026
Be Friends Holding Limited has granted a total of 6.45 million awarded shares at no purchase price to eight senior staff members under its share award plan, with 5.85 million shares allocated to seven senior employees and 600,000 shares to a senio...
Be Friends Holding Posts Slight Q1 GMV Decline Amid Focus on Live-Streaming Innovation
Apr 10, 2026
Be Friends Holding Limited reported that its group gross merchandise volume in the first quarter of 2026 exceeded RMB3.17 billion, reflecting a modest year-on-year decline of about 1.0% from the same period in 2025. The company framed the update a...
Be Friends Holding boosts 2025 revenue as it pivots to AI-driven new retail
Mar 26, 2026
Be Friends Holding Limited reported consolidated revenue of RMB1.55 billion for 2025, up 23.8% from the previous year, driven mainly by steady expansion of its Matrix Live Channel. Net profit rose 21.4% to RMB88 million, while adjusted net profit ...
Be Friends Holding Declares HKD 0.05 Final Dividend for 2025
Mar 26, 2026
Be Friends Holding Limited has declared a final ordinary cash dividend of HKD 0.05 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 16 June 2026. The dividend will be paid in Hong ...
Be Friends Holding Sets March Board Meeting to Approve 2025 Annual Results and Consider Dividend
Mar 16, 2026
Be Friends Holding Limited has scheduled a board meeting for 26 March 2026 to review and approve the group’s consolidated annual results for the financial year ended 31 December 2025 and to authorize their publication. The board will also co...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.